Početna › Kardiomiopatija › Pennsylvania
Kliničke studije za Kardiomiopatija u državi Pennsylvania
6 studija za Kardiomiopatija traži sudionike na lokacijama u državi Pennsylvania.
Gradovi u državi Pennsylvania
Službeni tekst studije (engleski)
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Lancaster
- Clinical Trial Site, Philadelphia
U tijeku regrutacijaFaza 3
Od 18 do 85 godina · Oba spola · Ažurirano 16. ruj 2026. · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Philadelphia
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT07358078Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Penn Presbyterian Medical Center, Philadelphia
- University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 4. kol 2026. · NCT06563895The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- University of Pennsylvania, Philadelphia
- UPMC, Pittsburgh
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 14. srp 2026. · NCT05034432A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Children's Hospital of Philadelphia, Philadelphia
U tijeku regrutacijaFaza 2
Od 8 godina i više · Muškarci · Ažurirano 4. svi 2026. · NCT06092034MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Penn Presbyterian Medical Center, Philadelphia
- Allegheny General Hospital, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
U tijeku regrutacijaFaza 3
Od 18 do 90 godina · Oba spola · Ažurirano 27. ožu 2026. · NCT06128629Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.